- Home
- Products
- Customized FluoroAb™
- CD19
- Blinatumomab-iFluor 350
Blinatumomab-iFluor 350 (CAT#: ADC-FL-379)
This product is comprised of an anti-CD19 (scFv-kappa-heavy)-(scFv-heavy-kappa) antibody (Blinatumomab) labeled with iFluor 350. iFluor 350 is a blue-fluorescent dye and it's excitation/emission is 346/442 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- CD19
- Alternative Names
- CD19; CD19 molecule; CD19 antigen; B-lymphocyte antigen CD19; differentiation antigen CD19; T-cell surface antigen Leu-12; B-lymphocyte surface antigen B4; B4; CVID3; MGC12802;
- Overview
- Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.
- Overview
- Anti-CD19 (scFv-kappa-heavy)-(scFv-heavy-kappa) antibody, Blinatumomab
- Generic name
- Blinatumomab
- Species Reactivity
- Human
- Name
- iFluor 350
- Color
- Blue
- Excitation⁄Emission (nm)
- 346/442
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Teneliximab-Cy5 (CAT#: ADC-FL-753)
- Anti-PDGFRA MAb (Clone 1)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5297)
- Anti-APP MAb (Clone 9)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS15500)
- Nimotuzumab-Fluoresein (CAT#: ADC-FL-1222)
- Anti-LTA MAb (Clone 15)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS4471)
- Anti-ERBB2 MAb (Clone 7)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS1892)
- Anti-ITGB2 MAb (Clone 2)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14494)
- Anti-FcRL5 MAb (Clone 3)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14840)
- Anti-FGFR2 MAb (Clone 11)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS9489)
- Anti-PDCD1 MAb (Clone 34)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS3018)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-FL-379. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-2516 | Anti-CD19 (Denintuzumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-780 | Anti-CD19 (Blinatumomab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-776 | Anti-CD19 (Blinatumomab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-322 | Anti-CD19-Mc-MMAF ADC-1 | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-775 | Anti-CD19 (Taplitumomab paptox)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
